Atossa Therapeutics
ATOS
#9776
Rank
A$61.78 M
Marketcap
A$7.17
Share price
-0.79%
Change (1 day)
553.74%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: A$61.78 Million

As of March 2026 Atossa Therapeutics has a market cap of A$61.78 Million. This makes Atossa Therapeutics the world's 9776th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026A$61.78 M-51.38%
2025A$0.12 B-35.96%
2024A$0.19 B22.6%
2023A$0.16 B64.58%
2022A$98.34 M-64.81%
2021A$0.27 B375.7%
2020A$58.74 M186.91%
2019A$20.47 M141.88%
2018A$8.46 M-21.04%
2017A$10.72 M44.68%
2016A$7.4 M-48.35%
2015A$14.34 M-66.58%
2014A$42.92 M-11.16%
2013A$48.31 M-0.36%
2012A$48.48 M

End of Day market cap according to different sources

On Mar 13th, 2026 the market cap of Atossa Therapeutics was reported to be:

A$61.78 Million
by Nasdaq info icon info icon
A$61.78 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$833.47 B 1,348,984.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$31.81 B 51,391.47%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$31.31 B 50,589.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$4.04 B 6,445.45%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A$1.46 B 2,270.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A$52.39 M-15.19%๐Ÿ‡บ๐Ÿ‡ธ USA